FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Kupersmith

Research Profile

Physiology

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Anatomy

Cavernous Sinus

Co-author Network

Publications

TOP 3
Mark Kupersmith; Mary Durbin; Melissa Horne; Randy Kardon; Julia Shulman
Scanning laser polarimetry reveals status of RNFL integrity in eyes with optic nerve head swelling by OCT.
Mark Kupersmith; Gary Mandel; Daniel Meltzer; Susan Anderson; Randy Kardon
Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI.
Mark Kupersmith; Gary Mandel; Patrick Sibony; Mary Durbin; Randy Kardon
Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Kupersmith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mark Kupersmith; Mary Durbin; Melissa Horne; Randy Kardon; Julia Shulman
Scanning laser polarimetry reveals status of RNFL integrity in eyes with optic nerve head swelling by OCT.
Investigative ophthalmology & visual science 2012;53(4):1962-70.
2011: Mark Kupersmith; Gary Mandel; Daniel Meltzer; Susan Anderson; Randy Kardon
Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI.
Journal of the neurological sciences 2011;308(1-2):117-23.
2011: Mark Kupersmith; Gary Mandel; Patrick Sibony; Mary Durbin; Randy Kardon
Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema.
Investigative ophthalmology & visual science 2011;52(9):6558-64.
2011: Patrick Sibony; Mark Kupersmith; F James Rohlf
Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy.
Investigative ophthalmology & visual science 2011;52(11):7987-95.
2010: Robert L Lesser; Jonathan Knisely; Silas L Wang; James B Yu; Mark Kupersmith
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.
The British journal of ophthalmology 2010;94(5):559-63.
2009: Valerie I Elmalem; Brian R Younge; Valérie Biousse; Jacqueline A Leavitt; Mark L Moster; Judith Warner; Mark Kupersmith; Klara Landau; Michael C Brodsky; Larry P Frohman; Eugene F May; Robert L Tomsak; Nancy J Newman
Clinical course and prognosis of trochlear nerve schwannomas.
Ophthalmology 2009;116(10):2011-6.
2009: Mark Kupersmith; Neil R Miller; Laura Balcer; Lynn Gordon; Michael Wall; John L Keltner; Deborah Friedman; Steven Feldon; Michael McDermott; Karl Kieburtz
The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC).
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2009;29(3):259-61.
2009: Mark Kupersmith
Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Journal of neurology 2009;256(8):1314-20.
2008: Mark Kupersmith
Practical classification of nystagmus in the clinic.
Archives of ophthalmology 2008;126(6):871-2; author reply 872.
2008: Yasunari Niimi; Mark Kupersmith; S Ahmad; J Song; Alejandro Berenstein
Cortical blindness, transient and otherwise, associated with detachable coil embolization of intracranial aneurysms.
AJNR. American journal of neuroradiology 2008;29(3):603-7.
2007: Mark Kupersmith; R L Gal; R W Beck; D Xing; Neil R Miller
Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.
Neurology 2007;69(6):508-14.
2007: Navraj S Heran; Joon K Song; Mark Kupersmith; Yasunari Niimi; Katsunari Namba; David Langer; Alejandro Berenstein
Large ophthalmic segment aneurysms with anterior optic pathway compression: assessment of anatomical and visual outcomes after endosaccular coil therapy.
Journal of neurosurgery 2007;106(6):968-75.
2007: Joon K Song; Yasunari Niimi; Mark Kupersmith; Alejandro Berenstein
Postnatal growth and development of a cerebral arteriovenous malformation on serial magnetic resonance imaging in a child with hemangiomatosis. Case report.
Journal of neurosurgery 2007;106(5 Suppl):384-7.
2006: Michael J Pro; Mauricio E Pons; Jeffrey M Liebmann; Robert Ritch; Samiah Zafar; Daniel Lefton; Mark Kupersmith
Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis.
Journal of the neurological sciences 2006;250(1-2):114-9.
2006: Alejandro Berenstein; Joon K Song; Yasunari Niimi; Katsunari Namba; Navraj S Heran; Jonathan L Brisman; M C Nahoum; Mary Madrid; David Langer; Mark Kupersmith
Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience.
AJNR. American journal of neuroradiology 2006;27(9):1834-40.
2006: Mark Kupersmith; Gordon Heller; Terry A Cox
Magnetic resonance angiography and clinical evaluation of third nerve palsies and posterior communicating artery aneurysms.
Journal of neurosurgery 2006;105(2):228-34.
2006: Jose De La Cruz; Mark Kupersmith
Clinical profile of simultaneous bilateral optic neuritis in adults.
The British journal of ophthalmology 2006;90(5):551-4.
2006: Mark Kupersmith
Are CD MRIs compatible with good neurological practice?
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2006;16(2):115-6.
2006: David Langer; Joon K Song; Yasunari Niimi; Mark Chwajol; Daniel Lefton; Jonathan L Brisman; Walter Molofsky; Mark Kupersmith; Alejandro Berenstein
Transarterial embolization of vein of Galen malformations: the use of magnetic resonance imaging noninvasive optimal vessel analysis to quantify shunt reduction. Report of two cases.
Journal of neurosurgery 2006;104(1 Suppl):41-5.
2005: Hadas Stiebel-Kalish; Yuval Kalish; Ruth Huna Bar-On; Avi Setton; Yasunari Niimi; Alejandro Berenstein; Mark Kupersmith
Presentation, natural history, and management of carotid cavernous aneurysms.
Neurosurgery 2005;57(5):850-7; discussion 850-7.
2005: Jonathan M Holmes; David A Leske; Mark Kupersmith
New methods for quantifying diplopia.
Ophthalmology 2005;112(11):2035-9.
2005: Mark Kupersmith; G Ying
Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
The British journal of ophthalmology 2005;89(10):1330-4.
2004: Roy W Beck; Craig H Smith; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Pamela S Moke; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Jonathan D Trobe; Michael Wall
Neurologic impairment 10 years after optic neuritis.
Archives of neurology 2004;61(9):1386-9.
2004: Joon K Song; Yasunari Niimi; Patricia M Fernandez; Jonathan L Brisman; Razvan Buciuc; Mark Kupersmith; Alejandro Berenstein
Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab.
AJNR. American journal of neuroradiology 2004;25(7):1147-53.
2004: Ravi K Tikoo; Mark Kupersmith; Jonathan Lester Finlay
Treatment of refractory neurosarcoidosis with cladribine.
The New England journal of medicine 2004;350(17):1798-9.
2004: Mark Kupersmith; V Martin; Gordon Heller; A Shah; HJ Mitnick
Idiopathic hypertrophic pachymeningitis.
Neurology 2004;62(5):686-94.
2004: Mark Kupersmith; Hilary E Fazzone
Comparing ocular muscle limitation tests for clinical trial use.
Archives of ophthalmology 2004;122(3):347-8.
2004: Mark Kupersmith
Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?
Journal of the neurological sciences 2004;217(2):123-4.
2004: Hadas Stiebel-Kalish; Lawrence S Turtel; Mark Kupersmith
The natural history of nontraumatic subarachnoid hemorrhage-related intraocular hemorrhages.
Retina (Philadelphia, Pa.) 2004;24(1):36-40.
2004: Roy W Beck; Robin L Gal; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Pamela S Moke; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Jonathan D Trobe; Michael Wall; Dongyuan Xing
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
American journal of ophthalmology 2004;137(1):77-83.
2003: Mark Kupersmith
Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2003;23(4):249-50.
2003: Hilary E Fazzone; Mark Kupersmith; J Leibmann
Does topical brimonidine tartrate help NAION?
The British journal of ophthalmology 2003;87(9):1193-4.
2003: Hilary E Fazzone; Daniel Lefton; Mark Kupersmith
Optic neuritis: correlation of pain and magnetic resonance imaging.
Ophthalmology 2003;110(8):1646-9.
2003: Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Archives of ophthalmology 2003;121(7):944-9.
2003: Robert Spiera; Mark Kupersmith; Stephen A Paget; Harry Spiera
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
Arthritis and rheumatism 2003;48(4):1159-60; author reply 1160-1.
2003: Mark Kupersmith; Robert Latkany; Peter Homel
Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Archives of neurology 2003;60(2):243-8.
2003: Hilary E Fazzone; Daniel Lefton; Mark Kupersmith
Acute occipital demyelinating lesion appearing as an infarct on diffusion magnetic resonance imaging.
American journal of ophthalmology 2003;135(1):96-7.
2002: Hadas Stiebel-Kalish; Avi Setton; Yassunari Nimii; Yuval Kalish; Jonathan Hartman; Ruth Huna Bar-On; Alejandro Berenstein; Mark Kupersmith
Cavernous sinus dural arteriovenous malformations: patterns of venous drainage are related to clinical signs and symptoms.
Ophthalmology 2002;109(9):1685-91.
2002: Ruth Huna-Baron; Mark Kupersmith
Idiopathic intracranial hypertension in pregnancy.
Journal of neurology 2002;249(8):1078-81.
2002: Hadas Stiebel-Kalish; Avi Setton; Alejandro Berenstein; Yuval Kalish; Y Nimii; Mark Kupersmith
Bilateral orbital signs predict cortical venous drainage in cavernous sinus dural AVMs.
Neurology 2002;58(10):1521-4.
2002: Roger E Turbin; Charlotte R Thompson; John S Kennerdell; Kimberly P Cockerham; Mark Kupersmith
A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy.
Ophthalmology 2002;109(5):890-9; discussion 899-900.
2002: Mark Kupersmith; Therese Alban; Barbara Zeiffer; Daniel Lefton
Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance.
Brain : a journal of neurology 2002;125(Pt 4):812-22.
2002: Mark Kupersmith; Hadas Stiebel-Kalish; Ruth Huna-Baron; Avi Setton; Yasunari Niimi; David Langer; Alejandro Berenstein
Cavernous carotid aneurysms rarely cause subarachnoid hemorrhage or major neurologic morbidity.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2002;11(1):9-14.
2001: Mark Kupersmith; R Speira; R Langer; M Richmond; M Peterson; H Speira; HJ Mitnick; Stephen A Paget
Visual function and quality of life among patients with giant cell (temporal) arteritis.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2001;21(4):266-73.
2001: Robert Spiera; HJ Mitnick; Mark Kupersmith; M Richmond; Harry Spiera; Margaret G E Peterson; Stephen A Paget
A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
Clinical and experimental rheumatology 2001;19(5):495-501.
2001: Ruth Huna-Baron; K Landau; M Rosenberg; FA Warren; Mark Kupersmith
Unilateral swollen disc due to increased intracranial pressure.
Neurology 2001;56(11):1588-90.
2001: Mark Kupersmith; H Kalish; Fred Epstein; G Yu; Alejandro Berenstein; H Woo; J Jafar; G Mandel; Francisco Jr. De Lara
Natural history of brainstem cavernous malformations.
Neurosurgery 2001;48(1):47-53; discussion 53-4.
2000: D Barr; Mark Kupersmith; Roger E Turbin; S Bose; R Roth
Isolated sixth nerve palsy: an uncommon presenting sign of multiple sclerosis.
Journal of neurology 2000;247(9):701-4.
2000: Ruth Huna-Baron; Avi Setton; Mark Kupersmith; Alejandro Berenstein
Orbital arteriovenous malformation mimicking cavernous sinus dural arteriovenous malformation.
The British journal of ophthalmology 2000;84(7):771-4.
2000: Ruth Huna-Baron; FA Warren; W Miller; J Jacobs; J Green; Mark Kupersmith
Mucosal leishmaniasis presenting as sinusitis and optic neuropathy.
Archives of ophthalmology 2000;118(6):852-4.
2000: S Andracchi; Mark Kupersmith; Peter Kim Nelson; Jason S Slakter; Avi Setton; Alejandro Berenstein
Visual loss from arterial steal in patients with maxillofacial arteriovenous malformation.
Ophthalmology 2000;107(4):730-6.
2000: D Barr; Mark Kupersmith; Roger E Turbin; S Yang; Raymond Iezzi Jr.
Synkinesis following diabetic third nerve palsy.
Archives of ophthalmology 2000;118(1):132-4.
1999: Ruth Huna-Baron; R L Lesser; FA Warren; C A Muszynski; Mark Kupersmith
Infantile cerebral aneurysms with visual pathway compression.
Pediatric neurosurgery 1999;31(6):322-5.
1999: D Barr; Mark Kupersmith; Richard Pinto; Roger E Turbin
Arachnoid cyst of the cavernous sinus resulting in third nerve palsy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 1999;19(4):249-51.
1999: Mark Kupersmith; R Langer; HJ Mitnick; Robert Spiera; Harry Spiera; M Richmond; Stephen A Paget
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
The British journal of ophthalmology 1999;83(7):796-801.
1999: Alejandro Berenstein; Eugene S Flamm; Mark Kupersmith
Unruptured intracranial aneurysms.
The New England journal of medicine 1999;340(18):1439-40; author reply 1441-2.
1999: Mark Kupersmith; Alejandro Berenstein; Peter Kim Nelson; H T ApSimon; Avi Setton
Visual symptoms with dural arteriovenous malformations draining into occipital veins.
Neurology 1999;52(1):156-62.
1998: Roger E Turbin; L St Louis; D Barr; Mark Kupersmith
Monocular band optic atrophy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 1998;18(4):242-5.
1998: Mark Kupersmith; L Gamell; Roger E Turbin; V Peck; P Spiegel; M Wall
Effects of weight loss on the course of idiopathic intracranial hypertension in women.
Neurology 1998;50(4):1094-8.
1997: Mark Kupersmith; L Frohman; M Sanderson; J Jacobs; J Hirschfeld; C Ku; FA Warren
Aspirin reduces the incidence of second eye NAION: a retrospective study.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 1997;17(4):250-3.
1997: Marc S Arginteanu; Karin Hague; R Zimmerman; Mark Kupersmith; J H Shaiu; J Schaeffer; Kalmon D Post
Craniopharyngioma arising de novo in middle age. Case report.
Journal of neurosurgery 1997;86(6):1046-8.
1996: Yasunari Niimi; Alejandro Berenstein; Avi Setton; Mark Kupersmith
Occlusion of the internal carotid artery based on a simple tolerance test.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 1996;2(4):289-96.
1996: Mark Kupersmith; M Moster; S Bhuiyan; F Warren; H Weinberg
Beneficial effects of corticosteroids on ocular myasthenia gravis.
Archives of neurology 1996;53(8):802-4.
1996: Mark Kupersmith
Techniques and surgical approach for transvenous embolization.
Archives of ophthalmology 1996;114(6):750.
1996: Mark Kupersmith; M E Vargas; A Yashar; M Madrid; K Nelson; A Seton; Alejandro Berenstein
Occipital arteriovenous malformations: visual disturbances and presentation.
Neurology 1996;46(4):953-7.
1996: Mark Kupersmith; E M Vargas; F Warren; Alejandro Berenstein
Venous obstruction as the cause of retinal/choroidal dysfunction associated with arteriovenous shunts in the cavernous sinus.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 1996;16(1):1-6.
1995: S Bose; Mark Kupersmith
Neuro-ophthalmologic presentations of functional visual disorders.
Neurologic clinics 1995;13(2):321-39.
1995: M E Vargas; Mark Kupersmith; P J Savino; F Petito; L P Frohman; F A Warren
Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease.
American journal of ophthalmology 1995;119(4):497-504.
1995: Robert W Hurst; Alejandro Berenstein; Mark Kupersmith; M Madrid; Eugene S Flamm
Deep central arteriovenous malformations of the brain: the role of endovascular treatment.
Journal of neurosurgery 1995;82(2):190-5.
1995: William Seiple; Mark Kupersmith; Karen Holopigian
Comparison of visual evoked potential and psychophysical contrast sensitivity.
The International journal of neuroscience 1995;80(1-4):173-80.
1994: H L Weiner; Jeffrey H Wisoff; M E Rosenberg; Mark Kupersmith; H Cohen; David Zagzag; T Shiminski-Maher; Eugene S Flamm; Fred J Epstein; D C Miller
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Neurosurgery 1994;35(6):1001-10; discussion 1010-1.
1994: Daiyan Xin; William Seiple; Karen Holopigian; Mark Kupersmith
Visual evoked potentials following abrupt contrast changes.
Vision research 1994;34(21):2813-21.
1994: Mark Kupersmith; C Rosenberg; David L Kleinberg
Visual loss in pregnant women with pituitary adenomas.
Annals of internal medicine 1994;121(7):473-7.
1994: M E Vargas; Mark Kupersmith; Avi Setton; K Nelson; Alejandro Berenstein
Endovascular treatment of giant aneurysms which cause visual loss.
Ophthalmology 1994;101(6):1091-8.
1994: Mark Kupersmith; M Vargas; W F Hoyt; Alejandro Berenstein
Optic tract atrophy with cerebral arteriovenous malformations: direct and transsynaptic degeneration.
Neurology 1994;44(1):80-3.
1994: Mark Kupersmith; D Kaufman; D W Paty; G Ebers; Henry McFarland; K Johnson; Stephen C Reingold; J Whitaker
Megadose corticosteroids in multiple sclerosis.
Neurology 1994;44(1):1-4.
1994: Karen Holopigian; L Clewner; William Seiple; Mark Kupersmith
The effects of dopamine blockade on the human flash electroretinogram.
Documenta ophthalmologica. Advances in ophthalmology 1994;86(1):1-10.
1993: Roy W Beck; P A Cleary; Jonathan D Trobe; D I Kaufman; Mark Kupersmith; D W Paty; Hendricks Brown
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
The New England journal of medicine 1993;329(24):1764-9.
1993: M E Vargas; F A Warren; Mark Kupersmith
Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy.
The British journal of ophthalmology 1993;77(12):822-3.
1993: J M Winterkorn; Mark Kupersmith; J D Wirtschafter; S Forman
Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.
The New England journal of medicine 1993;329(6):396-8.
1993: Roy W Beck; Mark Kupersmith; P A Cleary; Barrett D. Katz
Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
Ophthalmology 1993;100(5):691-7; discussion 697-8.
1993: Jafar J Jafar; A J Davis; Alejandro Berenstein; I S Choi; Mark Kupersmith
The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations.
Journal of neurosurgery 1993;78(1):60-9.
1992: M E Vargas; J R Desrouleaux; Mark Kupersmith
Ophthalmoplegia as a presenting manifestation of internal carotid artery dissection.
Journal of clinical neuro-ophthalmology 1992;12(4):268-71.
1992: Mark Kupersmith; R Hurst; Alejandro Berenstein; I S Choi; Jafar J Jafar; J Ransohoff
The benign course of cavernous carotid artery aneurysms.
Journal of neurosurgery 1992;77(5):690-3.
1992: Mark Kupersmith; William Seiple; Karen Holopigian; K Noble; E Hiesiger; F Warren
Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine.
American journal of ophthalmology 1992;113(4):435-8.
1992: Hilda Capo; F Warren; Mark Kupersmith
Evolution of oculomotor nerve palsies.
Journal of clinical neuro-ophthalmology 1992;12(1):21-5.
1992: Roy W Beck; P A Cleary; M M Anderson; John L Keltner; W T Shults; D I Kaufman; edward buckley; J J Corbett; Mark Kupersmith; Neil R Miller
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
The New England journal of medicine 1992;326(9):581-8.
1992: Robert W Hurst; I S Choi; M Persky; Mark Kupersmith
Mycotic aneurysms of the intracavernous carotid artery: a case report and review of the literature.
Surgical neurology 1992;37(2):142-6.
1991: Hilda Capo; Mark Kupersmith; Alejandro Berenstein; I S Choi; G A Diamond
The clinical importance of the inferolateral trunk of the internal carotid artery.
Neurosurgery 1991;28(5):733-7; discussion 737-8.
1991: Hilda Capo; Mark Kupersmith
Efficacy and complications of radiotherapy of anterior visual pathway tumors.
Neurologic clinics 1991;9(1):179-203.
1991: K G Noble; Mark Kupersmith
Spontaneous retinal capillary reperfusion in a systemic illness.
Archives of ophthalmology 1991;109(2):179-80.
1990: L Frohman; Mark Kupersmith; F Warren
The pituitary incidentaloma beyond the first year of follow-up.
JAMA : the journal of the American Medical Association 1990;264(18):2387.
1990: S C Rush; Mark Kupersmith; I Lerch; P Cooper; J Ransohoff; J Newall
Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas.
Journal of neurosurgery 1990;72(4):594-9.
1989: Mark Kupersmith; J Newall; J Ransohoff
Optic nerve sheath meningioma.
Journal of neurosurgery 1989;71(2):305.
1989: Mark Kupersmith; David L Kleinberg; F A Warren; G Budzilovitch; P Cooper
Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
Neurosurgery 1989;24(3):417-23.
1988: M J Gelwan; R I Kellen; R M Burde; Mark Kupersmith
Sarcoidosis of the anterior visual pathway: successes and failures.
Journal of neurology, neurosurgery, and psychiatry 1988;51(12):1473-80.
1988: Mark Kupersmith; R M Burde; F A Warren; T G Klingele; L P Frohman; H Mitnick
Autoimmune optic neuropathy: evaluation and treatment.
Journal of neurology, neurosurgery, and psychiatry 1988;51(11):1381-6.
1988: M J Gelwan; I S Choi; Alejandro Berenstein; John Pile-Spellman; Mark Kupersmith
Dural arteriovenous malformations and papilledema.
Neurosurgery 1988;22(6 Pt 1):1079-84.
1988: W Seiple; Mark Kupersmith; J Nelson; R Carr
Evoked potential assessment of cortical adaptation.
Applied optics 1988;27(6):1089-93.
1988: M J Gelwan; M Seidman; Mark Kupersmith
Pseudo-pseudo-Foster Kennedy syndrome.
Journal of clinical neuro-ophthalmology 1988;8(1):49-52.
1988: Mark Kupersmith; L P Frohman; I S Choi; S H Foo; E Hiesinger; Alejandro Berenstein; A Wise; R E Carr; J Ransohoff
Visual system toxicity following intra-arterial chemotherapy.
Neurology 1988;38(2):284-9.
1988: Mark Kupersmith; Alejandro Berenstein; I S Choi; F Warren; Eugene S Flamm
Management of nontraumatic vascular shunts involving the cavernous sinus.
Ophthalmology 1988;95(1):121-30.
1987: Mark Kupersmith; F A Warren; J Newall; J Ransohoff
Irradiation of meningiomas of the intracranial anterior visual pathway.
Annals of neurology 1987;21(2):131-7.
1987: T J Carlow; J Corbett; James A. Goodwin; Mark Kupersmith; R J Meckler; J Sharpe; C H Smith; M Wall
Controversies in diagnosis and management of pseudotumor cerebri.
Archives of neurology 1987;44(2):128-9.
1986: H Weinreb; J Klein; Mark Kupersmith
Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy.
New York state journal of medicine 1986;86(8):439-42.
1986: Mark Kupersmith; Alejandro Berenstein; Eugene S Flamm; J Ransohoff
Neuroophthalmologic abnormalities and intravascular therapy of traumatic carotid cavernous fistulas.
Ophthalmology 1986;93(7):906-12.
1986: Mark Kupersmith
Visual evoked potential: enhancing its utility.
Seminars in neurology 1986;6(2):217-30.
1986: L P Frohman; Mark Kupersmith; J Lang; D Reede; R T Bergeron; S Aleksic; S Trasi
Intracranial extension and bone destruction in orbital pseudotumor.
Archives of ophthalmology 1986;104(3):380-4.
1986: Mark Kupersmith; I M Siegel
Electrophysiological testing in neuroophthalmology.
International ophthalmology clinics 1986;26(4):175-95.
1985: D E Wiener; K Wellish; J I Nelson; Mark Kupersmith
Comparisons among Snellen, psychophysical, and evoked potential visual acuity determinations.
American journal of optometry and physiological optics 1985;62(10):669-79.
1985: A R Cohen; P R Cooper; Mark Kupersmith; Eugene S Flamm; J Ransohoff
Visual recovery after transsphenoidal removal of pituitary adenomas.
Neurosurgery 1985;17(3):446-52.
1985: L P Frohman; Mark Kupersmith
Reversible vertical ocular deviations associated with raised intracranial pressure.
Journal of clinical neuro-ophthalmology 1985;5(3):158-63.
1985: C Wertenbaker; Mark Kupersmith; M M Behrens
Monocular blindness with preserved pupillary reflexes.
Archives of neurology 1985;42(6):515-6.
1985: L P Frohman; F Epstein; Mark Kupersmith
Atypical visual prognosis with an optic nerve glioma.
Journal of clinical neuro-ophthalmology 1985;5(2):90-4.
1984: J I Nelson; William Seiple; Mark Kupersmith; R E Carr
A rapid evoked potential index of cortical adaptation.
Electroencephalography and clinical neurophysiology 1984;59(6):454-64.
1984: J I Nelson; William Seiple; Mark Kupersmith; R E Carr
Lock-in techniques for the swept stimulus evoked potential.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 1984;1(4):409-36.
1984: Mark Kupersmith; D Krohn
Cupping of the optic disc with compressive lesions of the anterior visual pathway.
Annals of ophthalmology 1984;16(10):948-53.
1984: K G Noble; Mark Kupersmith
Retinal vascular remodelling in radiation retinopathy.
The British journal of ophthalmology 1984;68(7):475-8.
1984: Mark Kupersmith; William Seiple; J I Nelson; Ronald E Carr
Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential.
Investigative ophthalmology & visual science 1984;25(6):632-9.
1984: William Seiple; Mark Kupersmith; J I Nelson; Ronald E Carr
The assessment of evoked potential contrast thresholds using real-time retrieval.
Investigative ophthalmology & visual science 1984;25(6):627-31.
1984: Mark Kupersmith; Alejandro Berenstein; I S Choi; J Ransohoff; Eugene S Flamm
Percutaneous transvascular treatment of giant carotid aneurysms: neuro-ophthalmologic findings.
Neurology 1984;34(3):328-35.
1984: J I Nelson; Mark Kupersmith; William Seiple; P A Weiss; Ronald E Carr
Spatiotemporal conditions which elicit or abolish the oblique effect in man: direct measurement with swept evoked potential.
Vision research 1984;24(6):579-86.
1984: Alejandro Berenstein; J Ransohoff; Mark Kupersmith; Eugene S Flamm; D Graeb
Transvascular treatment of giant aneurysms of the cavernous carotid and vertebral arteries. Functional investigation and embolization.
Surgical neurology 1984;21(1):3-12.
1984: Mark Kupersmith; J I Nelson; William Seiple; Ronald E Carr
Electrophysiological confirmation of orientation-specific contrast losses in multiple sclerosis.
Annals of the New York Academy of Sciences 1984;436():487-91.
1983: William Seiple; M J Price; Mark Kupersmith; I M Siegel; Ronald E Carr
The pattern electroretinogram in optic nerve disease.
Ophthalmology 1983;90(9):1127-32.
1983: Mark Kupersmith; J I Nelson; William Seiple; R E Carr; P A Weiss
The 20/20 eye in multiple sclerosis.
Neurology 1983;33(8):1015-20.
1983: Mark Kupersmith; P A Weiss; R E Carr
The visual-evoked potential in tobacco-alcohol and nutritional amblyopia.
American journal of ophthalmology 1983;95(3):307-14.
1982: Mark Kupersmith; E Shakin; I M Siegel; A Lieberman
Visual system abnormalities in patients with Parkinson's disease.
Archives of neurology 1982;39(5):284-6.
1982: Mark Kupersmith; I M Siegel; R E Carr
Subtle disturbances of vision with compressive lesions of the anterior visual pathway measured by contrast sensitivity.
Ophthalmology 1982;89(1):68-72.
1981: M Leibowitz; A Lieberman; M Goldstein; A Neophytides; Mark Kupersmith; G Gopinathan; S Mehl
Cardiac effects of pergolide.
Clinical pharmacology and therapeutics 1981;30(6):718-23.
1981: J Korein; A Lieberman; Mark Kupersmith; L Levidow
Effect of L-glutamine and isoniazid on torticollis and segmental dystonia.
Annals of neurology 1981;10(3):247-50.
1981: A Lieberman; M Goldstein; A Neophytides; Mark Kupersmith; M Leibowitz; N Zasorin; R Walker; D Kleinberg
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
Neurology 1981;31(8):961-5.
1981: Mark Kupersmith; I M Siegel; R E Carr; J Ransohoff; Eugene S Flamm; E Shakin
Visual evoked potentials in chiasmal gliomas in four adults.
Archives of neurology 1981;38(6):362-5.
1981: A Lieberman; M Goldstein; M Leibowitz; A Neophytides; Mark Kupersmith; V Pact; D Kleinberg
Treatment of advanced Parkinson disease with pergolide.
Neurology 1981;31(6):675-82.
1981: Mark Kupersmith; I M Siegel; R E Carr
Reduced contrast sensitivity in compressive lesions of the anterior visual pathway.
Neurology 1981;31(5):550-4.
1981: Mark Kupersmith; Alejandro Berenstein
Visual disturbances in von Hippel-Lindau disease.
Annals of ophthalmology 1981;13(2):195-7.
1980: Mark Kupersmith; A N Lieberman
The effect of specific brain lesions on the high affinity binding of GABA in the substantia nigra.
Brain research 1980;194(2):536-9.
1980: D L Kleinberg; A Lieberman; J Todd; J Greising; A Neophytides; Mark Kupersmith
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease.
The Journal of clinical endocrinology and metabolism 1980;51(1):152-4.
1980: A Lieberman; Mark Kupersmith; A Neophytides; I Casson; R Durso; S H Foo; M Khayali; G Bear; M Goldstein
Long-term efficacy of bromocriptine in Parkinson disease.
Neurology 1980;30(5):518-23.
1980: Mark Kupersmith; M Goldstein
The effect of decortication on the basal ganglia GABA receptor.
Neuroscience letters 1980;17(3):335-7.
1980: A Lieberman; M Dziatolowski; G Gopinathan; Mark Kupersmith; A Neophytides; J Korein
Evaluation of Parkinson's disease.
Advances in biochemical psychopharmacology 1980;23():277-86.
1980: A N Lieberman; Mark Kupersmith; A Neophytides; G Gopinathan; I Casson; R Durso; S H Foo; M Khayali; T Tartaro; M Goldstein
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Advances in biochemical psychopharmacology 1980;23():245-53.
1979: A N Lieberman; M Leibowitz; A Neophytides; Mark Kupersmith; S Mehl; D Kleinberg; Michael Serby; M Goldstein
Pergolide and lisuride for Parkinson's disease.
Lancet 1979;2(8152):1129-30.
1979: A Lieberman; M Dziatolowski; Mark Kupersmith; Michael Serby; A Goodgold; J Korein; M Goldstein
Dementia in Parkinson Disease.
Annals of neurology 1979;6(4):355-9.
1979: Mark Kupersmith; A N Lieberman; N Spielholz; P Berczeller; J Ransohoff
Neuropathy with susceptibility to compression aggravated by herniated disk. Early pathological and electrodiagnostic studies.
Archives of neurology 1979;36(10):645-7.
1979: A Lieberman; Mark Kupersmith; A Neophytides; I Casson; R Durso; S H Foo; M Khayali; T Tartaro
Bromocriptine mesylate in Parkinson's disease.
New York state journal of medicine 1979;79(11):1689-92.
1979: A Lieberman; A Neophytides; Mark Kupersmith; I Casson; R Durso; S H Foo; M Khayali; T Tartaro; M Goldstein
Treatment of Parkinson's disease with dopamine agonists: a review.
The American journal of the medical sciences 1979;278(1):65-76.
1979: Mark Kupersmith; W K Hass; N E Chase
Isoproterenol treatment of visual symptoms in migraine.
Stroke; a journal of cerebral circulation 1979;10(3):299-305.
1979: A N Lieberman; Mark Kupersmith; G Gopinathan; E Estey; A Goodgold; M Goldstein
Bromocriptine in Parkinson disease: further studies.
Neurology 1979;29(3):363-9.
1979: A N Lieberman; G Gopinathan; E Estey; Mark Kupersmith; A Goodgold; M Goldstein
Lergotrile in Parkinson disease: further studies.
Neurology 1979;29(2):267-72.
1978: A Lieberman; W K Hass; Richard Pinto; W O Isom; Mark Kupersmith; G Bear; R Chase
Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves.
Stroke; a journal of cerebral circulation 1978;9(1):18-24.
1977: A Lieberman; E Estey; Mark Kupersmith; G Gopinathan; M Goldstein
Treatment of Parkinson's disease with lergotrile mesylate.
JAMA : the journal of the American Medical Association 1977;238(22):2380-2.
1976: A Lieberman; Mark Kupersmith; E Estey; M Goldstein
Treatment of parkinson's disease with bromocriptine.
The New England journal of medicine 1976;295(25):1400-4.
1976: A N Lieberman; Mark Kupersmith; E Estey; M Goldstein
Lergotrile in Parkinson's disease.
Lancet 1976;1(7984):515-6.
1976: M A Gordon; R S Holzman; H Senter; E W Lapa; Mark Kupersmith
Aspergillus oryzae meningitis.
JAMA : the journal of the American Medical Association 1976;235(19):2122-3.
1975: B Boshes; R R Moody; Mark Kupersmith; A E Zeller
The role of monoamines in learning and memory consolidation.
International journal of neurology 1975;10(1-4):172-7.